Ark Surgical is developing the LapBox™ containment system, a fully contained space within the inflated abdomen that enables surgeons to morcellate large organs such as the uterus while reducing the risks associated with tissue morcellation. The company completed a first-in-human (FIH) study that the article reports demonstrated the system's safety and functionality/effectiveness. Led by CEO Stav Tori, Ark Surgical intends to use the newly raised funds to continue product development and progress along its pathway to market. The startup is based in Nazareth, Israel. The article states the company raised $2.1M in this financing. Participating backers included investors via the Together equity crowdfunding platform, the Israeli Innovation Authority, and NGT.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Jun 2021